SDSU IRB is a participating institution in the SMART IRB Reliance Agreement!
June 30, 2021
SDSU is now a participating institution in the nationwide SMART IRB Reliance system. Single IRB (sIRB) review is required for all federally funded research as of January 2020. There are some exceptions to this requirement. These exceptions can be found at the Office of Human Research Protections website and at the National Insitutes of Health (NIH) website. The SMART IRB reliance agreement facilitates sIRB review. The SMART IRB Reliance agreement can be invoked for non-federally funded research as well. As of June 30, 2021, there are 893 participating institutions. For cooperative, multisite studies, investigators can search to see if their collaborators are at a participating institution at this link. Information about the SMART IRB reliance system is included in a brief video. Resources for investigators and their study teams can be found here. Other information regarding policies and how to get started can be found on the SDSU SMART IRB webpage. The SDSU IRB webpage also includes consent templates so that SDSU investigators can share consent templates with their collaborators who rely on the SDSU IRB for review under the SMART IRB Reliance agreement. For more information or to schedule a meeting to discuss the SMART IRB reliance agreement with an IRB Analyst contact Anne Dodge-Schwanz, the SDSU SMART IRB Point of Contact (POC) or Pat Gordon the Alternate POC.
Virtual IRB "Office Hours"
UPDATE March 24, 2021
- Information regarding the use of Zoom in research and data security practices for sensitive data storage have been placed on the Guidance Page of the IRB website.
- Clinical Trials infomation https://research.sdsu.edu/research_affairs/human_subjects/clinical_trials
UPDATE September 11, 2020
UPDATE July 8, 2020
IRB Review Process for Email Requests to Pause Studies
1) An IRB Analyst will create a Reportable Event submission for the study team in the applicable study record in InfoEd.
2) A pdf of the email request will be added as a supporting document to the submission.
3) A “COVID-19 Acknowledgment” letter will be sent to the PI informing them that the study is now paused.
4) The status of the study is changed the "Paused"
Please note that the study is not closed and procedures that do not involve face-to-face contact with participants can continue.